Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001213900-15-009312
Filing Date
2015-12-07
Accepted
2015-12-07 11:28:34
Documents
1
Effectiveness Date
2015-12-07

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS defa14a1215_relmadatherap.htm DEFA14A 109938
  Complete submission text file 0001213900-15-009312.txt   111023
Mailing Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-702-7163
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 000-55347 | Film No.: 151271801
SIC: 2834 Pharmaceutical Preparations